Wells Fargo’s ARS Pharmaceuticals SPRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$244K Sell
30,385
-43,871
-59% -$420K ﹤0.01% 4591
2025
Q4
$865K Buy
74,256
+414
+0.6% +$4.03K ﹤0.01% 4083
2025
Q3
$742K Buy
73,842
+12,736
+21% +$183K ﹤0.01% 4018
2025
Q2
$1.07M Buy
61,106
+1,459
+2% +$21.1K ﹤0.01% 3653
2025
Q1
$750K Buy
59,647
+17,946
+43% +$216K ﹤0.01% 3839
2024
Q4
$440K Buy
41,701
+13,361
+47% +$187K ﹤0.01% 4264
2024
Q3
$411K Buy
28,340
+12,584
+80% +$150K ﹤0.01% 4123
2024
Q2
$134K Buy
15,756
+7,168
+83% +$63.6K ﹤0.01% 4770
2024
Q1
$87.8K Buy
8,588
+1,090
+15% +$8.13K ﹤0.01% 4966
2023
Q4
$41.1K Buy
7,498
+1,562
+26% +$6.84K ﹤0.01% 5345
2023
Q3
$22.4K Sell
5,936
-3,574
-38% -$23.5K ﹤0.01% 5551
2023
Q2
$63.7K Buy
9,510
+9,266
+3,798% +$61.8K ﹤0.01% 5303
2023
Q1
$1.59K Buy
244
+8
+3% +$61 ﹤0.01% 6265
2022
Q4
$2.01K Buy
236
+84
+55% +$545 ﹤0.01% 6013
2022
Q3
$1K Buy
152
+4
+3% +$20 ﹤0.01% 6461
2022
Q2
$1K Sell
148
-4,045
-96% -$14.1K ﹤0.01% 6596
2022
Q1
$14K Sell
4,193
-4,339
-51% -$18.9K ﹤0.01% 6156
2021
Q4
$57K Sell
8,532
-8,379
-50% -$68.1K ﹤0.01% 5913
2021
Q3
$169K Buy
16,911
+16,323
+2,776% +$403K ﹤0.01% 5175
2021
Q2
$18K Sell
588
-3,794
-87% -$122K ﹤0.01% 5946
2021
Q1
$191K Buy
+4,382
New +$207K ﹤0.01% 5177

Other funds holding SPRY